Bioengine entered the industry of Commercial Biotechnical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Andrea Estrada by calling (781) 391-6595 during business hours. You can also write to the business’ Single Location at 200 Boston Avenue # 1100, Medford, Massachusetts MA 02155. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Bioengine |
Representative: | Andrea Estrada |
Place of Business: | 200 Boston Avenue # 1100, Medford, MA 02155 |
Contact Number: | (781) 391-6595 |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 541711 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Bioengine is a company operating from Middlesex, Massachusetts providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Bioengine has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Andrea Estrada at (781) 391-6595 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 200 Boston Avenue # 1100 in Medford, Massachusetts 02155 and can be engaged online through the company website at , the company Twitter , and Facebook page .